LARRY WILKES: Open Payments
NPI 1942623525 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 9 payments from 6 companies in 2025. Trend: 2023 $212 · 2024 $0 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 4 | $405 |
| E.R. Squibb & Sons, L.L.C. | 1 | $144 |
| ABBVIE INC. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Lilly USA, LLC | 1 | $100 |
| Janssen Pharmaceuticals, Inc | 1 | $78 |
Products named: CYGNUS DUAL, COBENFY, VRAYLAR, PURAPLY WOUND MATRIX, INGREZZA, ZEPBOUND, INVEGA SUSTENNA, SIMPLIMAX.
Industry payments across IL — which companies pay providers there.
